Chemomab Therapeutics (CMMB) Enterprise Value Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.64% |
| Sep 30, 2025 | -6.70% |
| Jun 30, 2025 | -10.80% |
| Mar 31, 2025 | -78.86% |
| Dec 31, 2024 | 34.38% |
| Sep 30, 2024 | 27.65% |
| Jun 30, 2024 | 50.42% |
| Mar 31, 2024 | 85.51% |
| Dec 31, 2023 | 31.10% |
| Sep 30, 2023 | 80.17% |
| Jun 30, 2023 | 79.79% |
| Mar 31, 2023 | 43.03% |
| Dec 31, 2022 | 10.47% |
| Sep 30, 2022 | 27.58% |
| Jun 30, 2022 | 22.71% |
| Mar 31, 2022 | 1.37% |
| Dec 31, 2021 | -29.82% |
| Sep 30, 2021 | -849.59% |
| Jun 30, 2021 | -658.39% |
| Mar 31, 2021 | -311.77% |
| Dec 31, 2020 | 33.44% |
| Sep 30, 2020 | 79.12% |
| Jun 30, 2020 | 69.45% |
| Mar 31, 2020 | 56.01% |
| Dec 31, 2019 | -21.27% |
| Sep 30, 2019 | -2,129.16% |
| Jun 30, 2019 | -1,886.52% |
| Dec 31, 2018 | -896.70% |